NSEUpdates23h ago · 19 Aug 2026, 05:25 pm
Updates
Hexagon Nutrition Limited · HEXAGON
✦ AI SummaryPledge
Hexagon Nutrition Limited's Joint Managing Director, Dr. Nikhil Kelkar, has acquired 16,400 equity shares through open market transactions, increasing his stake in the company to 17.27%.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Hexagon Nutrition Limited has informed the Exchange regarding 'Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011, this is to inform you that Dr. Nikhil Kelkar, Promoter and Joint Managing Director of the Company acquired 16,400 Equity shares '.
Attachments (1)
📄pdf
Download →
HEXAGONNUTRITION_19082026172001_Intimation-Nikhil_Kelkar.pdf
View document text
HEXAGON NUTRITION LIMITED
'Nutritionally Yours...
Ref: HNL/SEC/2026-27/24 Date: 19th August 2026
Na(cid:415)onal Stock Exchange of India Limited BSE Limited
Lis(cid:415)ng & Compliance Department Lis(cid:415)ng Department
Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers,
Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001
Mumbai – 400051, Maharashtra, India Maharashtra, India
SYMBOL: HEXAGON Scrip Code: 544785
Dear Sir/Madam,
Ref: HEXAGON NUTRITION LIMITED - ISIN: INE0JUI01012
Subject: Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers),
Regulations, 2011 and Regulation 7 (2) of the Securities and Exchange Board of India (Prohibition of
Insider Trading) Regulations, 2015.
Pursuant to the provisions of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers),
Regulations, 2011 and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, this
is to inform you that Dr. Nikhil Kelkar, Promoter and Joint Managing Director of the Company acquired
16,400 Equity shares through open market transactions.
In accordance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers),
Regulations, 2011, we hereby submit the disclosure received from Dr. Nikhil Kelkar.
This is for your information and records.
Yours faithfully,
For Hexagon Nutrition Limited
Vedanti Vartak
Company Secretary and Compliance Officer
ICSI Membership No.: A41580
ENCL: Disclosures Under Regulation 29(2) of SEBI (SAST) Regulations, 2011
CIN:- L24110MH1993PLC072189
Nashlk Plant :
Registered Office :
Plot No. 92 & Plot No. 447, Unandanagar, Lakhamapur,
404 Global Chamber, Ada rsh Nagar, Link Road,
Dlndorl, Naslk - 422 202, Maharashtra, lndla
Andherl (W), Mumbai, Maharashtra - 400053, lndla
Tel., No.: +91-22-62136710/711
Chennal Plant :
Website : www.hexagonnutrltlon.com
Plot No. B11, Phase - 1 MEPZ-SEZ, Tambaram,
Emall ID: enqulry@hexagonnutrltlon.com
Chennal - 600 045, Tamil Nadu, India
DR. NIKHIL KELKAR, JOINT MANAGING DIRECTOR
National Stock Exchange of India Limited BSE Limited
Listing & Compliance Department Listing Department
Exchange Plaza, C-1, Block G, Floor 25, P J Towers,
Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai - 400001
Mumbai - 400051, Maharashtra, India. Maharashtra, India.
SYMBOL: HEXAGON Scrip Code: 544785
Sub: Submission of Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and
Takeovers). Regulations, 2011
Dear Sir/Madam,
With reference to Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations,
2011, Please find enclosed herewith Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of
Shares and Takeovers), Regulations, 2011 regarding acquisition of 16400 Equity Shares.
This is for your information and records.
Thanking you,
Yours faithfully,
NIKHIL ARUN {2;{8;w
KELKAR Date: 2026.08.18 09:45:01
+05'30'
Dr. Nikhil Kelkar
Promoter & Joint Managing Director
Encl: As above
CC: The Company Secretary & Compliance Officer
Hexagon Nutrition Limited
404, Global Chambers,
Off Link Road, Andheri (West),
Mumbai -400053
DR. NIKHIL KELKAR, JOINT MANAGING DIRECTOR
DISCLOSURES UNDER REGULATION 29(2) OE SEBI {SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS)
REGULATIONS, 2011
HEXAGON NUTRITION LIMITED
Name of the Target Company (TC}
DR. NIKHIL KELKAR
Name(s) of the acquirer and Persons Acting in Concert
(PAC} with the acquirer
Whether the acquirer belongs to Promoter/Promoter
group
1. National Stock Exchange of India Limited
Name(s) of the Stock Exchange(s) where the shares of TC
2. BSE Limited
are Listed
Number % w.r.t. total %w.r.t.
share/voting total diluted
Details of the acquisition/ disposal as follows capital share/voting
wherever capital of the
applicable(*) TC(**)
Before the acquisition under consideration, holding of :
a) Shares carrying voting rights
DR. NIKHIL ARUN KELKAR 2,12,16,068 17.26 % 17.26 %
b) Shares in the nature of encumbrance - - -
(pledge/ lien/ non-disposal undertaking/
others)
c) Voting rights (VR) otherwise than by shares - - -
d) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to
receive shares carrying voting rights in the TC
(specify holding in each category)
2,12,16,068 17.26% 17.26%
e) Total (a+b+c+d)
Details of acquisition/sale
a) Shares carrying voting rights acquired
DR. NIKHIL ARUN KELKAR 16,400 0.01 % 0.01%
b) VRs acquired /sold otherwise than by shares - - -
c) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) acquired/sold
d) Shares encumbered/ invoked/released by the - - -
acquirer
e) Total(a+b+c+/-d) 16,400 0.01% 0.01%
DR. NIKHIL KELKAR, JOINT MANAGING DIRECTOR
Number % w.r.t.total % w.r.t. total
After the acquisition/sale, holding of:
share/voting diluted
capital share/voting
wherever capital of the
applicable(*)
TC()
a) Shares carrying voting rights
DR. NIKHIL ARUN KELKAR 2,12,32,468 17.27 % 17.27 %
b) Shares encumbered with the acquirer - - -
c) VRs otherwise than by shares - - -
d) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to
receive shares carrying voting rights in the TC
(specify holding in each category) after
acquisition
2,12,32,468 17.27% 17.27%
e) Total (a+b+c+d)
OPEN MARKET
Mode of acquisition/ sale (e.g. open market/ off-market
/ public issue / rights issue / preferential allotment /
inter-se transfer etc).
17" August 2026
Date of acquisition/ sale of shares/ VR or date of receipt
of intimation of allotment of shares, whichever is
applicable
12,29,18,109
Equity share capital/ total voting capital of the TC before
the said acquisition/ sale
12,29,18,109
Equity share capital/ total voting capital of the TC
after the said acquisition/ sale
12,29,18,109
Total diluted share/voting capital of the TC after the
said acquisition
(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the
Stock Exchange under Clause 35 of the listing Agreement.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion
of the outstanding convertible securities/warrants into equity shares of the TC.
Signature of the acquirer
Dr. Nikhil Kelkar
Promoter and Joint Managing Director
Date: 18/08/2026